Publicacións en colaboración con investigadores/as de Hospital Universitario de Salamanca (17)

2022

  1. Long-Read Sequencing Identifies the First Retrotransposon Insertion and Resolves Structural Variants Causing Antithrombin Deficiency

    Thrombosis and Haemostasis, Vol. 122, Núm. 8, pp. 1369-1378

2021

  1. A decade of changes in management of immune thrombocytopenia, with special focus on elderly patients

    Blood Cells, Molecules, and Diseases, Vol. 86

  2. Author Correction: Deciphering predictive factors for choice of thrombopoietin receptor agonist, treatment free responses, and thrombotic events in immune thrombocytopenia (Scientific Reports, (2019), 9, 1, (16680), 10.1038/s41598-019-53209-y)

    Scientific Reports

  3. Expanding the genetic spectrum of TUBB1-related thrombocytopenia

    Blood Advances, Vol. 5, Núm. 24, pp. 5453-5467

2020

  1. Oral Anticoagulation and Risk of Symptomatic Hemorrhagic Transformation in Stroke Patients Treated With Mechanical Thrombectomy: Data From the Nordictus Registry

    Frontiers in Neurology, Vol. 11

2019

  1. Deciphering predictive factors for choice of thrombopoietin receptor agonist, treatment free responses, and thrombotic events in immune thrombocytopenia

    Scientific Reports, Vol. 9, Núm. 1

  2. Identification of 58 mutations (26 Novel) in 94 of 109 symptomatic Spanish probands with protein C deficiency

    Thrombosis and Haemostasis, Vol. 119, Núm. 9, pp. 1409-1418

  3. Involvement of antifactor VIII autoantibodies specificity in the outcome of inhibitor eradication therapies in acquired hemophilia a patients

    Blood Coagulation and Fibrinolysis, Vol. 30, Núm. 3, pp. 127-132

  4. Management of adult patients with primary immune thrombocytopenia (itp) in clinical practice: A consensus approach of the Spanish itp expert group

    Advances in Hematology, Vol. 2019

2018

  1. Introducing high-throughput sequencing into mainstream genetic diagnosis practice in inherited platelet disorders

    Haematologica, Vol. 103, Núm. 1, pp. 148-162

2010

  1. Pharmacogenetics of acenocoumarol in patients with extreme dose requirements

    Journal of Thrombosis and Haemostasis, Vol. 8, Núm. 5, pp. 1012-1017

1988

  1. Type IIB von Willebrand's disease associated with a complex thrombocytopenic thrombocytopathy

    American Journal of Hematology, Vol. 27, Núm. 4, pp. 291-298

1986

  1. The heterogeneity of Type IIA von Willebrand's disease: Studies with protease inhibitors

    Blood, Vol. 68, Núm. 6, pp. 1207-1212

  2. Unique multimeric pattern of von Willebrand factor in a patient with a benign monoclonal gammopathy

    Scandinavian Journal of Haematology, Vol. 36, Núm. 3, pp. 302-308

1985

  1. RESPUESTA AL DDAVP EN LA ENFERMEDAD DE VON WILLEBRAND TIPO II C

    Sangre, Vol. 30, Núm. 2, pp. 181-184

1984

  1. PERSPECTIVA ACTUAL DE LA ENFERMEDAD DE VON WILLEBRAND

    Anales de Medicina Interna, Vol. 1, Núm. 2, pp. 39-47

1981

  1. COMPLEMENTO Y EDEMA ANGIONEUROTICO HEREDITARIO. MECANISMO DE SUS INTERRELACIONES E INFLUENCIA DEL DANAZOL

    Medicina Clinica, Vol. 77, Núm. 9, pp. 380-385